A Consultant Surgeon in Liverpool has been awarded a major £2m fellowship to support groundbreaking research into emergency medicine.
Mr Rajarshi (Rishi) Mukherjee, a Consultant Surgeon in Emergency General and Major Trauma at NHS University Hospitals of Liverpool Group (UHLG), will focus his research on life threatening lung injury caused by conditions such as pancreatitis, trauma and sepsis.
The £2M Clinical Scientist award, from the Medical Research Council (MRC) and GlaxoSmithKline (GSK),is part of a MRC/GSK Development Fellowship scheme led by the University of Liverpool (UoL) to support groundbreaking research and develop the next-generation of leaders in medicines development.
Mr Mukherjee said: “Receiving this Fellowship is an incredible honour and the result of years dedicated to the advancement of drug discovery for inflammatory diseases.”
“These illnesses cause significant suffering to patients and through this research, I’m confident we can achieve transformative change in care, moving towards personalised treatment pathways that deliver far better outcomes.”
This Fellowship highlights the growing importance of combining clinical expertise with cutting-edge technology to transform healthcare. Working alongside the GSK AI and machine learning team, Rishi will analyse data from hundreds of patients to understand and treat Acute Respiratory Distress Syndrome (ARDS), a serious condition with high mortality rates.
Rishi continued: "AI and machine learning, combined with industry expertise, will give us unprecedented power to fast-track drug discovery.
“What once took decades can now be achieved in just a few years. We are standing on the brink of new medicine and it’s an incredibly exciting time to be part of this research revolution."